186 related articles for article (PubMed ID: 15311086)
1. Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences.
Meredith PA; Elliott HL
J Hypertens; 2004 Sep; 22(9):1641-8. PubMed ID: 15311086
[TBL] [Abstract][Full Text] [Related]
2. [24-hour perfect BP-lowering therapy using long-acting dihydropyridine calcium channel blockers].
Eguchi K
Nihon Rinsho; 2014 Aug; 72(8):1461-5. PubMed ID: 25167753
[TBL] [Abstract][Full Text] [Related]
3. The role of existing and newer calcium channel blockers in the treatment of hypertension.
Basile J
J Clin Hypertens (Greenwich); 2004 Nov; 6(11):621-29; quiz 630-1. PubMed ID: 15538095
[TBL] [Abstract][Full Text] [Related]
4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
6. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
Katz AM; Leach NM
J Clin Pharmacol; 1987 Nov; 27(11):825-34. PubMed ID: 3323259
[TBL] [Abstract][Full Text] [Related]
8. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association.
Wang JG; Kario K; Lau T; Wei YQ; Park CG; Kim CH; Huang J; Zhang W; Li Y; Yan P; Hu D;
Hypertens Res; 2011 Apr; 34(4):423-30. PubMed ID: 21228778
[TBL] [Abstract][Full Text] [Related]
9. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
10. Lercanidipine: a novel dihydropyridine calcium-channel blocker.
Epstein M
Heart Dis; 2001; 3(6):398-407. PubMed ID: 11975824
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine calcium channel antagonists in the management of hypertension.
Epstein BJ; Vogel K; Palmer BF
Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
[TBL] [Abstract][Full Text] [Related]
12. Dual calcium-channel blocker therapy in the treatment of hypertension.
Saseen JJ; Carter BL
Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
[TBL] [Abstract][Full Text] [Related]
13. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
14. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
Lee CR; Bryson HM
Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
[TBL] [Abstract][Full Text] [Related]
15. Anti-atherosclerotic potential of dihydropyridine calcium channel blockers.
Ishii N; Matsumura T; Shimoda S; Araki E
J Atheroscler Thromb; 2012; 19(8):693-704. PubMed ID: 22653165
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine calcium channel blockers and renal disease.
Robles NR; Fici F; Grassi G
Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
[TBL] [Abstract][Full Text] [Related]
17. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
18. Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific research.
Mason RP
Cerebrovasc Dis; 2003; 16 Suppl 3():11-7. PubMed ID: 12740551
[TBL] [Abstract][Full Text] [Related]
19. Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs.
Fardal Ø; Lygre H
J Clin Periodontol; 2015 Jul; 42(7):640-6. PubMed ID: 26076712
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
